Top 10 Hot Stocks with the Highest Upside Potential

7. AbCellera Biologics Inc. (NASDAQ:ABCL)

6-Month Performance: 113.29%

Average Price Target Upside Potential According to Analysts: 49.05%

AbCellera Biologics Inc. (NASDAQ:ABCL) ranks among the top 10 hot stocks with the highest upside potential. On June 5, AbCellera Biologics Inc. (NASDAQ:ABCL) reported that it has appointed Dr. Victor Sandor, M.D.C.M, to its Board of Directors as an independent director.

Dr. Sandor is a medical oncologist with extensive experience in developing companies and helping bring new medicines to patients. He previously served as Chief Medical Officer at Array BioPharma, where he played a key role in securing approval for Braftovi (encorafenib) and Mektovi (binimetinib).

Earlier, on May 21, Truist Securities increased its price target on AbCellera Biologics Inc. (NASDAQ:ABCL) from $10 to $12 while keeping its Buy rating on the stock. The firm pointed to positive Phase 1 results for ABCL-635, which showed target engagement and a clean safety profile. This could lead to a better safety profile than competitors.

The research firm said that it is now looking ahead to Phase 2 data expected in the third quarter of 2026. It expects the data to match or exceed the effectiveness seen with Veozah and Lynkuet. Truist believes AbCellera Biologics Inc. (NASDAQ:ABCL) offers an attractive risk-reward opportunity before those results are released.

AbCellera Biologics Inc. (NASDAQ:ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines for endocrinology, women’s health, immunology, and oncology.

1281292 - 11759070 - 1